Japanese Pharmaceuticals and Medical Devices Agency (PMDA) - Iyakuhinn Iryokiki Sogo Kiko
This article was originally published in RAJ Devices
You may also be interested in...
FDA seems poised to approve the drug for the orphan eye disease called TED, but remains concerned about labeling for some adverse events.
The apparently first-ever FDA press release for an advertising warning letter underscores importance of opioid issues – and the agency’s changing approach to media relations in general. FDA objects to Alkermes journal ad that excludes risk information about its opioid dependence treatment drug.